Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
Jharna Datta(The Ohio State University Wexner Medical Center), Mathew Cherian(The Ohio State University)
Cited by 20
Related Papers
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
|Journal of Biological Chemistry|2018|27
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|Breast Cancer Research|2024|7
Augmentation of extracellular ATP synergizes with chemotherapy in triple negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0
Sulfatase 2 Inhibition Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy Through Augmentation of Extracellular ATP
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0